Youssef Erfanian1, Johannes Grueneisen2, Julian Kirchner3, Axel Wetter2, Lars Erik Podleska4, Sebastian Bauer5, Thorsten Poeppel6, Michael Forsting2, Ken Herrmann6, Lale Umutlu2. 1. Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany. Youssef.erfanian@uk-essen.de. 2. Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany. 3. Department of Diagnostic and Interventional Radiology, University Hospital Dusseldorf, University of Dusseldorf, Dusseldorf, Germany. 4. Sarcoma Surgery Division, Department of General-, Visceral- and Transplantation Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. 5. Division of Solid Tumor Translational Oncology, Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. 6. Clinic for Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Abstract
PURPOSE: To assess and compare the diagnostic accuracy of PET/MRI and MRI alone for the detection of local recurrences of soft tissue sarcomas (STS) after initial surgical resection of the primary tumors. MATERIAL AND METHODS: A total of 41 patients with clinically suspected tumor relapse of STS underwent an 18F-FDG-PET/MRI examination for assessment of local recurrence. Two experienced physicians interpreted the MRI data and subsequently the PET/MRI datasets in two separate reading sessions and were instructed to identify potential local tumor recurrences. Additionally, the diagnostic confidence in each reading for the identification of malignant lesions was determined. A McNemar test was applied to test for differences of both ratings and a Wilcoxon signed-rank test was used to identify differences of the confidence levels. Histopathological verification and follow-up imaging were applied for standard of reference. RESULTS: Tumor relapse was present in 27/41 patients. Calculated sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy for the detection of local tumor recurrence was 82%, 86%, 92%, 71% and 83% for MRI, and 96%, 79%, 90%, 92% and 90% for PET/MRI (p > 0.05). Furthermore, PET/MRI showed significantly higher confidence levels (p < 0.05) for the determination of malignant lesions. CONCLUSION: Our results endorse 18F-FDG PET/MRI to be an excellent imaging method in the evaluation of recurrent STS after surgical excision, yielding superior tumor detection when compared to MRI alone.
PURPOSE: To assess and compare the diagnostic accuracy of PET/MRI and MRI alone for the detection of local recurrences of soft tissue sarcomas (STS) after initial surgical resection of the primary tumors. MATERIAL AND METHODS: A total of 41 patients with clinically suspected tumor relapse of STS underwent an 18F-FDG-PET/MRI examination for assessment of local recurrence. Two experienced physicians interpreted the MRI data and subsequently the PET/MRI datasets in two separate reading sessions and were instructed to identify potential local tumor recurrences. Additionally, the diagnostic confidence in each reading for the identification of malignant lesions was determined. A McNemar test was applied to test for differences of both ratings and a Wilcoxon signed-rank test was used to identify differences of the confidence levels. Histopathological verification and follow-up imaging were applied for standard of reference. RESULTS:Tumor relapse was present in 27/41 patients. Calculated sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy for the detection of local tumor recurrence was 82%, 86%, 92%, 71% and 83% for MRI, and 96%, 79%, 90%, 92% and 90% for PET/MRI (p > 0.05). Furthermore, PET/MRI showed significantly higher confidence levels (p < 0.05) for the determination of malignant lesions. CONCLUSION: Our results endorse 18F-FDG PET/MRI to be an excellent imaging method in the evaluation of recurrent STS after surgical excision, yielding superior tumor detection when compared to MRI alone.
Authors: Sasan Partovi; Andres A Kohan; Lisa Zipp; Peter Faulhaber; Christos Kosmas; Pablo R Ros; Mark R Robbin Journal: Int J Clin Exp Med Date: 2014-03-15
Authors: Ken Herrmann; Matthias R Benz; Johannes Czernin; Martin S Allen-Auerbach; William D Tap; Sarah M Dry; Tibor Schuster; Jeff J Eckardt; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber Journal: Clin Cancer Res Date: 2012-02-14 Impact factor: 12.531
Authors: P Heusch; C Buchbender; J Köhler; F Nensa; K Beiderwellen; H Kühl; R S Lanzman; H J Wittsack; B Gomez; T Gauler; M Schuler; M Forsting; A Bockisch; G Antoch; T A Heusner Journal: Rofo Date: 2013-07-16
Authors: Andrei Iagaru; Rinat Masamed; Sant P Chawla; Lawrence R Menendez; Alex Fedenko; Peter S Conti Journal: Clin Nucl Med Date: 2008-01 Impact factor: 7.794
Authors: Markus K Schuler; Stephan Richter; Bettina Beuthien-Baumann; Ivan Platzek; Jörg Kotzerke; Jörg van den Hoff; Gerhard Ehninger; Peter Reichardt Journal: Case Rep Oncol Med Date: 2013-07-01
Authors: Johannes Grueneisen; Karsten Beiderwellen; Philipp Heusch; Paul Buderath; Bahriye Aktas; Marcel Gratz; Michael Forsting; Thomas Lauenstein; Verena Ruhlmann; Lale Umutlu Journal: PLoS One Date: 2014-05-07 Impact factor: 3.240
Authors: Abhijit J Chaudhari; William Y Raynor; Ali Gholamrezanezhad; Thomas J Werner; Chamith S Rajapakse; Abass Alavi Journal: PET Clin Date: 2021-01
Authors: Amani Arthur; Edward W Johnston; Jessica M Winfield; Matthew D Blackledge; Robin L Jones; Paul H Huang; Christina Messiou Journal: Front Oncol Date: 2022-07-01 Impact factor: 5.738